These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2959322)

  • 21. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).
    Nieuwenhuizen W; Gravesen M
    Biochim Biophys Acta; 1981 Mar; 668(1):81-8. PubMed ID: 6453618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
    Dang CV; Bell WR; Ebert RF; Starksen NF
    Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinopeptide B and aggregation of fibrinogen.
    Shainoff JR; Dardik BN
    Science; 1979 Apr; 204(4389):200-2. PubMed ID: 155308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheological behaviors of bovine blood forming artificial rouleaux.
    Kaibara M
    Biorheology; 1983; 20(5):583-92. PubMed ID: 6203573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
    Marder VJ; Budzynski AZ; Barlow GH
    Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinopeptide A binds Gly-Pro-Arg-Pro.
    Root-Bernstein RS; Westall FC
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4339-42. PubMed ID: 6589598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
    Sato H; Swadesh JK
    Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
    Shainoff JR; Stearns DJ; DiBello PM; Hishikawa-Itoh Y
    Thromb Haemost; 1990 Apr; 63(2):193-203. PubMed ID: 2163552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Owen J; Friedman KD; Grossman BA; Wilkins C; Berke AD; Powers ER
    J Clin Invest; 1987 Jun; 79(6):1642-7. PubMed ID: 2953761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation pathway of fibrinogen by plasmin.
    Budzynski AZ; Marder VJ
    Thromb Haemost; 1977 Dec; 38(4):793-800. PubMed ID: 146273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of fibrinogen specific binding in erythrocyte aggregation.
    Lominadze D; Dean WL
    FEBS Lett; 2002 Apr; 517(1-3):41-4. PubMed ID: 12062406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein.
    Sturge J; Carey N; Davies AH; Powell JT
    J Vasc Surg; 2001 Apr; 33(4):847-53. PubMed ID: 11296341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats.
    Ruhenstroth-Bauer G; Scherer R; Hornberger M; Tongendorff G
    Inflammation; 1981 Dec; 5(4):343-51. PubMed ID: 7327698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca.
    Kamiguti AS; Slupsky JR; Zuzel M; Hay CR
    Thromb Haemost; 1994 Aug; 72(2):244-9. PubMed ID: 7831660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.